In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose […]
The post Enhanced warnings for opioid pain medications appeared first on Health Newstrack.